Sun’s Ilumya India Price Play Seen Reflecting ‘Global Discipline’

 
• By Anju Ghangurde
  
Injectables
Sun debuts top-selling specialty therapy in India (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from India